Secured Research | Equipment Finance Originator | Monitor | Monitor Suite | Converge | STRIPES Leadership
No Result
View All Result
ABF Journal
Forward for Specialty Finance
SUBSCRIBE
Lender & Services Directory
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
  • Contact Us
  • News
    • People
    • Economy
    • All News
  • Deals
  • Magazine
    • Magazine Issues
    • Nominations
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Events
  • Recruiting
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Advertise
  • Contact Us
No Result
View All Result
ABF Journal
No Result
View All Result
Home Deal Announcements

Aquestive Therapeutics Completes $150MM Debt Refinancing with Oaktree

At closing, Oaktree provided $55 million, which was primarily used to repay the company’s existing loan in the aggregate principal amount of $45 million plus fees associated with such repayment.

byBrianna Wilson
May 13, 2026
in Deal Announcements, News

Aquestive Therapeutics, a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, refinanced its existing debt facility with a new $150 million debt facility with funds managed by Oaktree Capital Management.

This transaction provides additional flexibility to fund the launch of Anaphylm, if approved by the FDA. At closing, Oaktree provided $55 million, which was primarily used to repay the company’s existing loan in the aggregate principal amount of $45 million plus fees associated with such repayment. Upon United States Food and Drug Administration (FDA) approval of Anaphylm and satisfaction of other customary conditions, an additional $20 million will be available. A third tranche of $25 million will be available upon the achievement of specified sales milestones, with the final tranche of up to $50 million available with the mutual consent of the lenders and the company. The company will pay only interest on the new five-year facility with all principal amounts outstanding due at maturity.

“We are excited to begin our relationship with Oaktree, a well-established leader within life sciences debt financing,” Daniel Barber, CEO of Aquestive Therapeutics, said. “The new $150 million debt facility will help Aquestive drive growth for years to come. With this agreement, we reduce our principal debt repayments over the next three years from $45 million to zero, reduce our interest rate when compared to the previous debt agreement, complete the pre-approval requirements under our strategic funding agreement with RTW Investments, L.P., and unlock additional capital for the potential launch of Anaphylm, if approved by the FDA.”

Rahul Anand, managing director, life sciences lending at Oaktree, added, “We are delighted to be partnering with Aquestive at this exciting stage in the company’s development and believe that Anaphylm has the potential to be a truly transformative rescue treatment for patients suffering from severe allergic reactions, including anaphylaxis. This transaction underscores Oaktree’s commitment to provide scalable capital solutions to companies developing novel medicines. We look forward to supporting the Aquestive management team as they work on bringing this important therapy to patients and healthcare providers globally.”

Cantor Fitzgerald acted as the sole placement agent to Aquestive. Dechert acted as counsel to Aquestive and Morgan, Lewis & Bockius served as counsel to Oaktree.

Previous Post

JPalmer Collective Provides $3.5MM Asset-Based Line of Credit to Pangaea

Next Post

Siena Lending Group Agents $175MM Credit Facility for Phillips Pet Food and Supplies

Related Posts

News

Middle Market Debt Weekly: December Locked in a Hike as the 10-Year Breaks 5%

November 16, 2026
News

Porter Capital Launches Term Loans and Lines of Credit

November 16, 2026
Deal Announcements

Assembled Brands Delivers $12.5MM Revolving Credit Facility to Sports Nutrition and Energy Drink Company

November 16, 2026
Deal Announcements

eCapital Provides $10MM ABL Facility to Support Food Manufacturer’s Growth

November 16, 2026
Wingspire Capital Provides Over $500MM in Corporate Finance Commitments in H1/25
News

BriteCap Financial Completes 2026 SOC 2 Type II Recertification

November 16, 2026
Deal Announcements

Ameresco Secures $125MM Nuveen Facility for European Growth

November 16, 2026
Next Post
Advanced Power Closes $100M Corporate Credit Facility

Siena Lending Group Agents $175MM Credit Facility for Phillips Pet Food and Supplies

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About Us

For over 50 years, RAM Holdings’ brands have led the commercial finance industry in publishing, talent development, research and events. ABF Journal’s audience is comprised of as many as 18,000 specialty finance industry executives, private equity investors, investment bankers, advisors, service providers and more.

Our Brands

  • Secured Research
  • Equipment Finance Originator
  • Monitor
  • Monitor Suite
  • Converge
  • STRIPES Leadership

 

Learn More

  • Advertise
  • Magazine
  • Contact Us

Newsletter

Driving specialty finance forward for decades with insights, recognition and deals. Sign up now.

SUBSCRIBE >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • People
    • Economy
    • All News
  • Deals
  • Features
    • Articles & Insights
    • Resolving MCA Distress
    • Resolving Business Distress
  • Magazine
    • Magazine Issues
    • Nominations
  • Molloy Associates
    • Molloy Associates Senior Asset Based Lending Originator Location: Remote
  • Events
  • Advertise
  • Contact Us
Provider Directory >>

© 2025 RAM Group Holdings - A Leading Commercial Finance Publishing Group For Over 50 Years